Prostate Cancer - Results from #24140

Personalized management in low-risk prostate cancer: The role of biomarkers - Abstract February 6, 2013

Vitamin D levels in subjects with prostate cancer compared to age-matched controls - Abstract February 6, 2013

A rectourethral fistula due to transrectal high-intensity focused ultrasound treatment: Diagnosis and management - Abstract February 6, 2013

Segmental dosimetry, toxicity and long-term outcome in patients with prostate cancer treated with permanent seed implants - Abstract February 6, 2013

Diabetes predicts metastasis after radical prostatectomy in obese men: Results from the SEARCH database - Abstract February 6, 2013

Large urology group spotlight on Lancaster Urology Group: An evolutionary approach to an ADT clinic where bone health is a priority, Interview with Paul R. Sieber, MD February 5, 2013

Enzalutamide: A novel anti-androgen for patients with castrate resistant prostate cancer - Abstract February 5, 2013

Optimizing the management of high-risk, localized prostate cancer - Abstract February 5, 2013

Biochemical recurrence in Gleason score 7 prostate cancer in Korean men: Significance of the primary Gleason grade - Abstract February 5, 2013

Usefulness of a combined approach of T1-weighted, T2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer - Abstract February 5, 2013

Prostate cancer with clear cell features and an unusual nested-like pattern of growth: A case report - Abstract February 5, 2013

Men's experiences of regaining urinary continence following robotic-assisted laparoscopic prostatectomy (RALP) for localised prostate cancer: A qualitative phenomenological study - Abstract February 5, 2013

The accuracy of pathological data for the prediction of insignificant prostate cancer - Abstract February 5, 2013

Immunotherapy with Sipuleucel-T (APC8015) in patients with metastatic castration-refractory prostate cancer (mCRPC): A systematic review and meta-analysis - Abstract February 5, 2013

Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer - Abstract February 4, 2013

Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene - Abstract February 4, 2013

External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection - Abstract February 4, 2013

Opium consumption is negatively associated with serum prostate-specific antigen (PSA), free PSA, and percentage of free PSA levels - Abstract February 4, 2013

How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden - Abstract February 4, 2013

An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection - Abstract February 4, 2013

Page 1208 of 1447